Sera Prognostics, Inc. (SERA)
2.18
+0.04
(+1.87%)
USD |
NASDAQ |
Aug 24, 16:00
2.15
-0.03
(-1.38%)
After-Hours: 20:00
Sera Prognostics Enterprise Value : 42.53M for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 42.53M |
| August 21, 2026 | 40.95M |
| August 20, 2026 | 39.38M |
| August 19, 2026 | 35.04M |
| August 18, 2026 | 32.67M |
| August 17, 2026 | 33.46M |
| August 14, 2026 | 33.85M |
| August 13, 2026 | 35.83M |
| August 12, 2026 | 36.22M |
| August 11, 2026 | 35.04M |
| August 10, 2026 | 35.83M |
| August 07, 2026 | 38.19M |
| August 06, 2026 | 35.43M |
| August 05, 2026 | 35.43M |
| August 04, 2026 | 32.67M |
| August 03, 2026 | 39.38M |
| July 31, 2026 | 37.01M |
| July 30, 2026 | 39.38M |
| July 29, 2026 | 37.40M |
| July 28, 2026 | 36.62M |
| July 27, 2026 | 37.40M |
| July 24, 2026 | 37.40M |
| July 23, 2026 | 42.14M |
| July 22, 2026 | 38.59M |
| July 21, 2026 | 46.08M |
| Date | Value |
|---|---|
| July 20, 2026 | 39.38M |
| July 17, 2026 | 37.40M |
| July 16, 2026 | 43.32M |
| July 15, 2026 | 41.74M |
| July 14, 2026 | 34.64M |
| July 13, 2026 | 32.28M |
| July 10, 2026 | 34.25M |
| July 09, 2026 | 37.80M |
| July 08, 2026 | 37.40M |
| July 07, 2026 | 35.83M |
| July 06, 2026 | 38.98M |
| July 02, 2026 | 35.43M |
| July 01, 2026 | 36.62M |
| June 30, 2026 | 28.33M |
| June 29, 2026 | 25.95M |
| June 26, 2026 | 25.56M |
| June 25, 2026 | 25.56M |
| June 24, 2026 | 25.56M |
| June 23, 2026 | 27.13M |
| June 22, 2026 | 27.52M |
| June 18, 2026 | 23.61M |
| June 17, 2026 | 29.09M |
| June 16, 2026 | 27.91M |
| June 15, 2026 | 27.13M |
| June 12, 2026 | 28.30M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Myriad Genetics, Inc. | 386.88M |
| BioRestorative Therapies, Inc. | 1.874M |
| CareDx, Inc. | 2.091B |
| Natera, Inc. | 46.21B |
| Exagen, Inc. | 188.15M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.139M |
| Revenue (Quarterly) | 0.03M |
| Total Expenses (Quarterly) | 9.169M |
| EPS Diluted (Quarterly) | -0.181 |
| Gross Profit Margin (Quarterly) | -606.7% |
| Profit Margin (Quarterly) | -30.46K% |
| Earnings Yield | -30.44% |
| Normalized Earnings Yield | -30.44 |